ahlam1399
09-30-2016, 01:00 AM
Alcobra plunges after FDA places hold on ADHD drug
(Reuters) - Alcobra Ltd's market value more than halved on Thursday, a day after the company said the U.S. Food and Drug Administration had placed a hold on its lead experimental drug. http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=o5ncDBQAfyU:OWtzRGQ5G_M:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=o5ncDBQAfyU:OWtzRGQ5G_M:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=o5ncDBQAfyU:OWtzRGQ5G_M:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=o5ncDBQAfyU:OWtzRGQ5G_M:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=o5ncDBQAfyU:OWtzRGQ5G_M:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/o5ncDBQAfyU
(Reuters) - Alcobra Ltd's market value more than halved on Thursday, a day after the company said the U.S. Food and Drug Administration had placed a hold on its lead experimental drug. http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=o5ncDBQAfyU:OWtzRGQ5G_M:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=o5ncDBQAfyU:OWtzRGQ5G_M:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=o5ncDBQAfyU:OWtzRGQ5G_M:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=o5ncDBQAfyU:OWtzRGQ5G_M:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=o5ncDBQAfyU:OWtzRGQ5G_M:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/o5ncDBQAfyU